Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of S-1 and Irinotecan Combination Chemotherapy in Patients With Advanced Gastric Cancer as a First-Line Therapy

NCT00343668 is registered in ClinicalTrials.gov with Korean Cancer Study Group as lead sponsor.

NCT NCT00343668
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00343668 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of S-1 and Irinotecan Combination Chemotherapy in Patients With Advanced Gastric Cancer as a First-Line Therapy
Lead sponsor
Korean Cancer Study Group
Phase
Phase 2
Overall status
Unknown status
Start date
September 30, 2005
Completion date
July 31, 2008
Enrollment
44 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer